Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Suzuki, H.
Right arrow Articles by Watanabe, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suzuki, H.
Right arrow Articles by Watanabe, K.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Q J Med 2002; 95: 128-130
© 2002 Association of Physicians

Correspondence

Recovery from renal failure in malignant hypertension associated with primary aldosteronism: effect of an ACE inhibitor

H. Suzuki, K. Asano, M. Eiro, M. Kuriki, S. Hashimoto, T. Katoh and T. Watanabe

Department of Internal Medicine III

K. Watanabe

Department of Pathology, Fukushima Medical University School of Medicine, Fukushima, Japan

Sir,

Primary aldosteronism is one of the most common causes of secondary hypertension. However, it is rare for this disease to induce malignant hypertension associated with vascular organ damage including renal failure.1 One of the reasons for this is that, even in the malignant phase, renin activity and subsequent angiotensin II production remain suppressed in primary aldosteronism. Here, we report a case with aldosterone-producing adenoma and increased renin activity complicated by malignant hypertension and renal failure, which required haemodialysis therapy. This case is noteworthy, because medical therapy with angiotensin-converting enzyme (ACE) inhibitor effectively improved renal function, allowing discontinuation of dialysis.

A 40-year-old woman . . . [Full Text of this Article]

References


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 The Annals of PharmacotherapyHome page
C. D Bubbar, D. F Blackburn, M. P Wilson, and T. W Wilson
Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Hypertension Due to Primary Aldosteronism: A Case for Exclusion
Ann. Pharmacother., January 1, 2007; 41(1): 129 - 132.
[Abstract] [Full Text] [PDF]